Wall Street Tries To Guess The Impact Of Pandemic On Medtech Revenues

24 Mar 2020

As the pandemic unfolds with an uncertain outcome, US securities analysts that cover publicly traded medtech companies are developing mathematical models to estimate the impact of the COVID-19 pandemic on medtech companies.

Global economy pandemic fear and economic coronavirus fear or virus outbreak and Stock market fears as a bull and bear sick financial health as a business recession with 3D illustration elements. — • Source: shutterstock.com

US securities analysts are trying to estimate the impact of the COVID-19 pandemic on the performance of medtech companies by building mathematical models that account for disruption of supply chains and the widespread deferral of elective procedures.

Following the outbreak of COVID-19 in China at the end of 2019, most medtech companies addressed the impact of COVID-19...